Clinical Trial Update: A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for oral AT2101 (afegostat tartrate) in treatment-naive Gaucher disease patients completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease
• Gaucher Disease Type

Drugs mentioned

• AT2101

Snippet

Sponsor: Amicus Therapeutics | Conditions: Gaucher Disease, Type 1 Gaucher Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-08-15